Templeman Thomas 4
4 · Centessa Pharmaceuticals plc · Filed Jul 6, 2022
Insider Transaction Report
Form 4
Templeman Thomas
Chief Technology Officer
Transactions
- Award
Ordinary Shares
2022-07-01+140,000→ 140,250 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.